AU2016209321B2 - Anthelmintic compounds, compositions and method of using thereof - Google Patents

Anthelmintic compounds, compositions and method of using thereof Download PDF

Info

Publication number
AU2016209321B2
AU2016209321B2 AU2016209321A AU2016209321A AU2016209321B2 AU 2016209321 B2 AU2016209321 B2 AU 2016209321B2 AU 2016209321 A AU2016209321 A AU 2016209321A AU 2016209321 A AU2016209321 A AU 2016209321A AU 2016209321 B2 AU2016209321 B2 AU 2016209321B2
Authority
AU
Australia
Prior art keywords
diyl
alkyl
ring
group
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2016209321A
Other languages
English (en)
Other versions
AU2016209321A1 (en
Inventor
Alan Long
Douglas Edward Wilkinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Boehringer Ingelheim Animal Health USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Animal Health USA Inc filed Critical Boehringer Ingelheim Animal Health USA Inc
Publication of AU2016209321A1 publication Critical patent/AU2016209321A1/en
Assigned to Boehringer Ingelheim Animal Health USA Inc. reassignment Boehringer Ingelheim Animal Health USA Inc. Request for Assignment Assignors: MERIAL, INC.
Priority to AU2019202773A priority Critical patent/AU2019202773B2/en
Application granted granted Critical
Publication of AU2016209321B2 publication Critical patent/AU2016209321B2/en
Priority to AU2020204400A priority patent/AU2020204400A1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU2016209321A 2015-01-20 2016-01-20 Anthelmintic compounds, compositions and method of using thereof Ceased AU2016209321B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2019202773A AU2019202773B2 (en) 2015-01-20 2019-04-18 Anthelmintic Compounds, Compositions And Method Of Using Thereof
AU2020204400A AU2020204400A1 (en) 2015-01-20 2020-06-30 Anthelmintic compounds, compositions and method of using thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562105463P 2015-01-20 2015-01-20
US62/105,463 2015-01-20
PCT/US2016/014148 WO2016118638A1 (en) 2015-01-20 2016-01-20 Anthelmintic compounds, compositions and method of using thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2019202773A Division AU2019202773B2 (en) 2015-01-20 2019-04-18 Anthelmintic Compounds, Compositions And Method Of Using Thereof

Publications (2)

Publication Number Publication Date
AU2016209321A1 AU2016209321A1 (en) 2017-08-17
AU2016209321B2 true AU2016209321B2 (en) 2019-05-09

Family

ID=55299781

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2016209321A Ceased AU2016209321B2 (en) 2015-01-20 2016-01-20 Anthelmintic compounds, compositions and method of using thereof
AU2019202773A Ceased AU2019202773B2 (en) 2015-01-20 2019-04-18 Anthelmintic Compounds, Compositions And Method Of Using Thereof
AU2020204400A Abandoned AU2020204400A1 (en) 2015-01-20 2020-06-30 Anthelmintic compounds, compositions and method of using thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2019202773A Ceased AU2019202773B2 (en) 2015-01-20 2019-04-18 Anthelmintic Compounds, Compositions And Method Of Using Thereof
AU2020204400A Abandoned AU2020204400A1 (en) 2015-01-20 2020-06-30 Anthelmintic compounds, compositions and method of using thereof

Country Status (11)

Country Link
US (1) US10597364B2 (enExample)
EP (1) EP3247701B1 (enExample)
JP (1) JP6771469B2 (enExample)
CN (1) CN107257793A (enExample)
AU (3) AU2016209321B2 (enExample)
BR (1) BR112017015273A2 (enExample)
CA (1) CA2973873A1 (enExample)
ES (1) ES2907461T3 (enExample)
MX (1) MX379304B (enExample)
NZ (1) NZ734082A (enExample)
WO (1) WO2016118638A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2545964A1 (en) 2011-07-13 2013-01-16 Phenex Pharmaceuticals AG Novel FXR (NR1H4) binding and activity modulating compounds
SI3730487T1 (sl) 2016-06-13 2022-08-31 Gilead Sciences, Inc. Azetidinski derivati kot modulatorji FXR (NR1H4)
CA3252823A1 (en) 2016-06-13 2025-02-25 Gilead Sciences, Inc. Fxr (nr1h4) modulating compounds
HRP20241015T1 (hr) 2016-07-20 2024-11-08 Novartis Ag Derivati aminopiridina i njihova uporaba kao selektivnih alk-2 inhibitora
KR102743630B1 (ko) 2017-03-28 2024-12-18 길리애드 사이언시즈, 인코포레이티드 간 질환을 치료하기 위한 치료 조합물
RU2020105929A (ru) 2017-08-04 2021-09-06 Скайхоук Терапьютикс, Инк. Способы и композиции для модулирования сплайсинга
TWI793151B (zh) 2017-08-23 2023-02-21 瑞士商諾華公司 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途
AR116109A1 (es) 2018-07-10 2021-03-31 Novartis Ag Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos
MX2021000309A (es) 2018-07-10 2021-04-12 Novartis Ag Derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-dion a y su uso en el tratamiento de enfermedades dependientes del dedo de zinc 2 de la familia ikaros (ikzf2).
AR116524A1 (es) * 2018-10-04 2021-05-19 Elanco Tiergesundheit Ag Potenciación de tratamiento de helmintos
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
GB201820626D0 (en) * 2018-12-18 2019-01-30 Univ Of Canterbury Conjugates
FI3911647T3 (fi) 2019-01-15 2024-03-01 Gilead Sciences Inc Isoksatsoliyhdiste fxr-agonistina ja sitä käsittäviä lääkekoostumuksia
MX2021008661A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.
JP7603592B2 (ja) 2019-02-05 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
KR20210123344A (ko) 2019-02-05 2021-10-13 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물
CN119528905A (zh) 2019-02-06 2025-02-28 斯基霍克疗法公司 用于调节剪接的方法和组合物
CA3129949C (en) 2019-02-19 2024-04-30 Gilead Sciences, Inc. Solid forms of fxr agonists
PE20220281A1 (es) * 2019-03-19 2022-02-25 Boehringer Ingelheim Animal Health Usa Inc Compuestos de aza-benzotiofeno y aza-benzofurano como antihelminticos
UY38687A (es) 2019-05-17 2023-05-15 Novartis Ag Inhibidores del inflamasoma nlrp3, composiciones, combinaciones de los mismos y métodos para su uso
US11129829B2 (en) 2019-06-17 2021-09-28 Skyhawk Therapeutics, Inc. Methods for modulating splicing
UA130060C2 (uk) 2019-10-25 2025-10-29 Гіліад Сайєнсіз, Інк. Сполуки, які модулюють glp-1r
AU2020388638A1 (en) 2019-11-22 2022-06-30 Incyte Corporation Combination therapy comprising an ALK2 inhibitor and a JAK2 inhibitor
AU2021212669B2 (en) 2020-01-29 2023-10-26 Gilead Sciences, Inc. GLP-1R modulating compounds
IL298219A (en) 2020-05-15 2023-01-01 Algen Biotechnologies Inc Certain chemical compositions and methods of use thereof
JP2023530316A (ja) 2020-06-16 2023-07-14 インサイト・コーポレイション 貧血の治療のためのａｌｋ２阻害剤
EP4247804A1 (en) 2020-11-20 2023-09-27 Gilead Sciences, Inc. Polyheterocyclic glp-1 r modulating compounds
EP4304711A1 (en) 2021-03-11 2024-01-17 Gilead Sciences, Inc. Glp-1r modulating compounds
US12180197B2 (en) 2021-03-11 2024-12-31 Gilead Sciences, Inc. GLP-1R modulating compounds
US11932630B2 (en) 2021-04-16 2024-03-19 Novartis Ag Heteroaryl aminopropanol derivatives
CA3216163A1 (en) 2021-04-21 2022-10-27 Gilead Sciences, Inc. Carboxy-benzimidazole glp-1r modulating compounds
UY40374A (es) 2022-08-03 2024-02-15 Novartis Ag Inhibidores de inflamasoma nlrp3

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031072A1 (en) * 1997-12-18 1999-06-24 E.I. Du Pont De Nemours And Company Cyclohexylamine arthropodicides and fungicides
EP1403255A1 (en) * 2001-06-12 2004-03-31 Sumitomo Pharmaceuticals Company, Limited Rho KINASE INHIBITORS
WO2007006389A1 (de) * 2005-07-14 2007-01-18 Merck Patent Gmbh Mischung von onium-alkylsulfonaten und onium-alkylsulfiten
WO2011044001A1 (en) * 2009-10-09 2011-04-14 Irm Llc Compounds and compositions as modulators of gpr119 activity
WO2011143495A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
WO2011143366A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
WO2013098373A1 (en) * 2011-12-29 2013-07-04 Boehringer Ingelheim International Gmbh New azetidine derivatives, pharmaceutical compositions and uses thereof
WO2014023723A1 (en) * 2012-08-08 2014-02-13 Novartis Ag Subtituted azines as pesticides
US20140142114A1 (en) * 2012-11-20 2014-05-22 Merial Limited Anthelmintic compounds and compositions and method of using thereof
WO2014159690A1 (en) * 2013-03-12 2014-10-02 Vertex Pharmaceuticals Incorporated Dna-pk inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4208254A1 (de) 1992-03-14 1993-09-16 Hoechst Ag Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid
AU2001231202A1 (en) 2000-01-28 2001-08-07 Akkadix Corporation Methods for killing nematodes and nematode eggs using 4-phenoxy-6-aminopyrimidine derivatives
JP4948173B2 (ja) * 2003-10-10 2012-06-06 ニツポネツクス・インコーポレーテツド 過剰増殖性疾患治療用ピリミジン誘導体
CA2564355C (en) * 2004-05-07 2012-07-03 Amgen Inc. Protein kinase modulators and method of use
WO2007063839A1 (ja) * 2005-11-30 2007-06-07 Shionogi & Co., Ltd. シクロヘキサン誘導体
TW200938203A (en) 2007-12-17 2009-09-16 Intervet Int Bv Anthelmintic agents and their use
TW201041868A (en) * 2009-03-20 2010-12-01 Intervet Int Bv Anthelmintic agents and their use
TW201111358A (en) 2009-06-18 2011-04-01 Intervet Int Bv Anthelmintic agents and their use
EP2468096A1 (en) 2010-12-21 2012-06-27 Intervet International BV Anthelmintic combinations
MX369104B (es) 2013-11-18 2019-10-29 Elanco Tiergesundheit Ag Nuevos compuestos.
JP6616786B2 (ja) 2014-05-19 2019-12-04 メリアル インコーポレイテッド 駆虫性化合物

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031072A1 (en) * 1997-12-18 1999-06-24 E.I. Du Pont De Nemours And Company Cyclohexylamine arthropodicides and fungicides
EP1403255A1 (en) * 2001-06-12 2004-03-31 Sumitomo Pharmaceuticals Company, Limited Rho KINASE INHIBITORS
WO2007006389A1 (de) * 2005-07-14 2007-01-18 Merck Patent Gmbh Mischung von onium-alkylsulfonaten und onium-alkylsulfiten
WO2011044001A1 (en) * 2009-10-09 2011-04-14 Irm Llc Compounds and compositions as modulators of gpr119 activity
WO2011143495A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
WO2011143366A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
WO2013098373A1 (en) * 2011-12-29 2013-07-04 Boehringer Ingelheim International Gmbh New azetidine derivatives, pharmaceutical compositions and uses thereof
WO2014023723A1 (en) * 2012-08-08 2014-02-13 Novartis Ag Subtituted azines as pesticides
US20140142114A1 (en) * 2012-11-20 2014-05-22 Merial Limited Anthelmintic compounds and compositions and method of using thereof
WO2014159690A1 (en) * 2013-03-12 2014-10-02 Vertex Pharmaceuticals Incorporated Dna-pk inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CAS RN: 1350249-77-2; Entered STN 07 December 2011; N-[cis-4-[[5-(4-methyl-1-piperazinyl)-1H-indazol-4-yl]oxy]cyclohexyl]-benzenamine *

Also Published As

Publication number Publication date
WO2016118638A1 (en) 2016-07-28
CA2973873A1 (en) 2016-07-28
EP3247701A1 (en) 2017-11-29
JP6771469B2 (ja) 2020-10-21
AU2016209321A1 (en) 2017-08-17
AU2020204400A1 (en) 2020-07-30
NZ734082A (en) 2019-01-25
US10597364B2 (en) 2020-03-24
AU2019202773A1 (en) 2019-05-16
MX379304B (es) 2025-03-11
US20180009754A1 (en) 2018-01-11
CN107257793A (zh) 2017-10-17
AU2019202773B2 (en) 2020-07-02
JP2018502877A (ja) 2018-02-01
EP3247701B1 (en) 2021-09-22
ES2907461T3 (es) 2022-04-25
BR112017015273A2 (pt) 2018-01-09
MX2017009408A (es) 2017-10-02

Similar Documents

Publication Publication Date Title
AU2016209321B2 (en) Anthelmintic compounds, compositions and method of using thereof
US10463661B2 (en) Anthelmintic compounds
AU2017200135B2 (en) Anthelmintic compounds and compositions and method of using thereof
HK1258916B (en) Anthelmintic compounds and compositions and method of using thereof
OA17714A (en) Anthelmintic compounds and compositions and method of using thereof.

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.

Free format text: FORMER APPLICANT(S): MERIAL, INC.

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired